-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation